IJMS | Free Full-Text | Estrogen Receptors-Mediated Apoptosis in Hormone-Dependent Cancers
The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)
Dual-mechanism estrogen receptor inhibitors | PNAS
Expression of receptor activator of NFkB (RANK) drives stemness and resistance to therapy in ER+HER2- breast cancer | Oncotarget
Fulvestrant-Induced Cell Death and Proteasomal Degradation of Estrogen Receptor α Protein in MCF-7 Cells Require the CSK c-Src Tyrosine Kinase | PLOS ONE
Estrogen receptor-α signaling in post-natal mammary development and breast cancers | SpringerLink
Dual-mechanism estrogen receptor inhibitors | PNAS
Selective Estrogen Receptor Degraders (SERDs): A Promising Strategy for Estrogen Receptor Positive Endocrine-Resistant Breast Cancer | Journal of Medicinal Chemistry
Cancers | Free Full-Text | Nexus between PI3K/AKT and Estrogen Receptor Signaling in Breast Cancer
Endocrinotherapy resistance of prostate and breast cancer: Importance of the NF‑κB pathway (Review)
Estrogen receptor positive breast cancers have patient specific hormone sensitivities and rely on progesterone receptor | Nature Communications
Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action | British Journal of Cancer
Crosstalk between Estrogen Signaling and Breast Cancer Metabolism: Trends in Endocrinology & Metabolism
The interaction between ER and NFκB in resistance to endocrine therapy | Breast Cancer Research | Full Text
Cells | Free Full-Text | Endocrine Resistance in Breast Cancer: The Role of Estrogen Receptor Stability
Frontiers | Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action | British Journal of Cancer
Transrepression of estrogen receptor and NFκB. (a) NFκB can inhibit... | Download Scientific Diagram
Targeting estrogen receptor α for degradation with PROTACs: A promising approach to overcome endocrine resistance - ScienceDirect
A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling - ScienceDirect
IJMS | Free Full-Text | Estrogen Receptors-Mediated Apoptosis in Hormone-Dependent Cancers
Fulvestrant (R enantiomer) (ICI 182780 (R enantiomer)) | Estrogen Receptor/ERR | MedChemExpress
エストロゲン/プロゲストゲン受容体阻害 | Androgen Receptor Inhibition
